Abstract ISI
CIRCULATION  (2012)

Dipeptidyl Peptidase-4 Inhibitors May Reduce the Risk of Major Adverse Cardiovascular Events and All-cause Mortality In Patients With Type 2 Diabetes: Meta-analyses Oof Randomized Controlled Trials

Sun X.; Hazzan, AA; Bala M.; Russe, JW; Johnston, BC; Carrasco Labra, A; Jankowski, M; Neumann, I; Ferreira-Gonzaalez, I; Fernandez-Balsells, M; Rios, L; Bassler D.; Briel, M; Lopes L.; Nordmann A.; et. al.